Cartesian Therapeutics Price Target Maintained With a $41.00/Share by Needham

Needham維持Cartesian Therapeutics的目標股價爲41.00美元/股

道瓊斯 · 11/25 07:24 · 評級/大行評級

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.